support from National Key R&D Program of China(2022YFE0209700);the National Natural Science Foundation of China(82070406,82000080,and 82304486);Guangdong Provincial Drug Administration Science and Technology Innovation Program(2023ZDZ05,2022ZDZ10,China);supported by a funding from the Department of Science and Technology of Guangdong to AS(2024A1515010574,China).
Pulmonary fibrosis poses a significant health threat with very limited therapeutic options available.In this study,we reported the enhanced expression of mesenchymal homobox 1(MEOX1)in pulmonary fibrosis patients,espe...
Radiation induced fibrosis(RIF)can be understood as a form of chronic radiation-induced bystander effect(RIBE).It is a fibrotic process different than acute radiation syndrome(ARS),which is an inflammatory process tha...
This study was funded by the Beijing University of Chinese Medicine(2018-zxfzjj-002);by the project of Beijing University of Chinese Medicine and Beijing Tong Ren Tang Company Limited Scientific Research Institute(2020071720310).
Objective:To investigate the therapeutic effects and pharmacological mechanisms of Yishen Xingyang capsule(YXC)in oligoasthenospermia(OA)rats.Methods:Forty-eight male SpragueeDawley rats were randomly divided into eig...
This study was supported by the National Natural Science Foundation of China of China(No.81573716).
Objective:Overexpression of microRNA-21(miR-21)has been well-recognized during fibrosis in a wide range of tissue types through regulation of fibrogenesis via diverse pathways.Curcumin exhibits antifibrotic effects in...
The Xinjiang Uygur Autonomous Region Natural Science Foundation(number:2015172B022).
Objective: To observe the effects of Irbesartan combined with Atorvastatin on early diabetic nephropathy patients' serum Cys C, Hcy, TNF-α, ET and TGF-b1 levels. Methods: A total of 60 early diabetic nephropathy pati...